-
Celltrion, Inc. (Korean: 주식회사 셀트리온) is a
biopharmaceutical company headquartered in Incheon,
South Korea.
Celltrion Healthcare conducts worldwide marketing...
- 2023, he
owned 97.2% of
Celltrion Holdings,
which in turn
owned 23% of
Celltrion, 55% of
Celltrion Pharm, and 24.3% of
Celltrion Healthcare. Seo has two...
-
Celltrion Entertainment Co., Ltd. (formerly
known as
Dream E&M Co., Ltd.) is a
South Korean production and
artist management company under the Celltrion...
- Remsima) were
submitted for
approval in the
European Union, by
Hospira and
Celltrion Healthcare respectively. Both had a
positive opinion from
European Medicines...
-
School following the
expiration of her contract. On May 10, Park
joined Celltrion Entertainment. On July 3 it was
announced that Park had
changed her promotional...
-
directed against the
spike protein of SARS-CoV-2. It is
developed by
Celltrion. The
medicine is
given by
infusion (drip) into a vein. The most common...
- Brzoska, CEO,
InPost Group (Poland); and
JungJin SEO,
Honorary Chairman,
Celltrion Group (South Korea). Periodically,
global leaders are
bestowed awards...
-
include Hyundai Motors,
Samsung Electronics, LG Electronics, Kia, SK Hynix,
Celltrion, Posco, Krafton, Hancom, and NCSoft. The
steel industry plays a key role...
-
prescription drugs marketed in the Asia-Pacific
region to
South Korea's
Celltrion in a deal
worth $278 million. Also in 2020,
Takeda sold
TachoSil to Corza...
-
giant cell
tumor of bone. The
applicant for this
medicinal product is
Celltrion Healthcare Hungary Kft.
Osenvelt is a
biosimilar medicinal product. It...
